USPTO serial 90251467
XLENTI
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- DINALLO, KEVIN M
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with XLENTI?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Gracell Bioscience (Shanghai) Co., Ltd.
Shanghai,, CN
Other trademarks owned by Gracell Bioscience (Shanghai) Co., Ltd.
Gracell Biotechnology (Shanghai) Co., Ltd.
Shanghai,, CN
Other trademarks owned by Gracell Biotechnology (Shanghai) Co., Ltd.
Gracell Biotechnology (Shanghai) Co., Ltd.
Shanghai,, CN
Other trademarks owned by Gracell Biotechnology (Shanghai) Co., Ltd.
Gracell Bioscience (Shanghai) Co., Ltd.
Shanghai,, CN
Other trademarks owned by Gracell Bioscience (Shanghai) Co., Ltd.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joe McKinney Muncy
Joe McKinney Muncy Muncy, Geissler, Olds & Lowe, P.C.125 S. Royal StreetAlexandria, VA 22314United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Biological preparations for the treatment of cancer; Biological tissue cultures for medical purposes; Cellular function activating agents for medical purposes; Diagnostic biomarker reagents for medical purposes; Gases and gas mixtures for medical imaging use; Living cells for medical use; Mixed biological preparations for the prevention and treatment of infectious diseases; Nutritionally fortified water for medical purposes; Nutritive substances for microorganisms for medical purposes; Stem cells for medical purposes | ACTIVE | — |
| 042 | Biochemical research and analysis; Biological research; Biomedical research services; Conducting clinical trials for others; Medical research services in the field of cancer; Pharmaceutical drug development services; Pharmaceutical product evaluation; Research and development services in the field of antibodies; Stem cell research services; Structural and functional analysis of genomes | ACTIVE | — |
| 044 | Cognitive therapy services; Genetic testing for medical purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical consultations; Medical counseling relating to disease risk; Medical information; Medical services; Medical and pharmaceutical consultation; Performing diagnosis of diseases; Providing medical information; Stem cell therapy services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Gracell Bioscience (Shanghai) Co., Ltd.
- Other trademarks owned by Gracell Biotechnology (Shanghai) Co., Ltd.
- Other trademarks owned by Gracell Biotechnology (Shanghai) Co., Ltd.
- Other trademarks owned by Gracell Bioscience (Shanghai) Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named XLENTI
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 22, 2024 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jul 22, 2024 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Jan 5, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 4, 2024 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Jan 3, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 12, 2023 | EXT5 | SOU EXTENSION 5 FILED | — |
| Dec 12, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 16, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 14, 2023 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jun 14, 2023 | EXT4 | SOU EXTENSION 4 FILED | — |
| Jun 14, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 16, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 14, 2022 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 14, 2022 | EXT3 | SOU EXTENSION 3 FILED | — |
| Dec 14, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 11, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 9, 2022 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 9, 2022 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jun 9, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 15, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Dec 13, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 13, 2021 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 13, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 15, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 20, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 20, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 31, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 12, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 12, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 12, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 12, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 12, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 12, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 1, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 16, 2020 | NWAP | NEW APPLICATION ENTERED | — |